Dianthus Therapeutics, Inc.

General ticker "DNTH" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.0B (TTM average)

Dianthus Therapeutics, Inc. follows the US Stock Market performance with the rate: 49.8%.

Estimated limits based on current volatility of 3.7%: low 77.43$, high 83.39$

Factors to consider:

  • Total employees count: 53 as of 2023
  • Current price 41.1% above estimated high
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [25.44$, 58.05$]
  • 2026-12-31 to 2027-12-31 estimated range: [17.21$, 41.83$]

Financial Metrics affecting the DNTH estimates:

  • Negative: with PPE of -10.3 at the end of fiscal year the price was very high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: Shareholder equity ratio, % of 92.93 > 64.29
  • Positive: Inventory ratio change, % of -29.71 <= -0.75
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: -14.17 < Investing cash flow per share per price, % of -7.72

Similar symbols

Short-term DNTH quotes

Long-term DNTH plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $2.83MM $6.24MM $2.04MM
Operating Expenses $51.00MM $108.10MM $179.97MM
Operating Income $-48.17MM $-101.86MM $-177.93MM
Non-Operating Income $4.62MM $16.89MM $15.60MM
R&D Expense $32.84MM $83.11MM $145.64MM
Income(Loss) $-43.55MM $-84.97MM $-162.34MM
Net Income(Loss)* $-43.55MM $-84.97MM $-162.34MM
Stockholders Equity $168.87MM $352.48MM $493.40MM
Assets $179.41MM $374.01MM $530.92MM
Operating Cash Flow $-36.86MM $-78.18MM $-129.06MM
Capital expenditure $0.11MM $0.10MM $0.21MM
Investing Cash Flow $20.25MM $-286.81MM $-122.83MM
Financing Cash Flow $133.57MM $255.62MM $280.12MM
Earnings Per Share** $-8.45 $-2.55 $-4.30

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.